Sudden Death and Use of Stimulant Medications in Youths

Objective: The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. Method: A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of psychiatry Vol. 166; no. 9; pp. 992 - 1001
Main Authors Gould, Madelyn S., Walsh, B. Timothy, Munfakh, Jimmie Lou, Kleinman, Marjorie, Duan, Naihua, Olfson, Mark, Greenhill, Laurence, Cooper, Thomas
Format Journal Article
LanguageEnglish
Published Arlington, VA American Psychiatric Association 01.09.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective: The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. Method: A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates. Results: In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings. Conclusions: This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment.
AbstractList Objective: The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. Method: A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates. Results: In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings. Conclusions: This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment.
The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents.OBJECTIVEThe authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents.A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates.METHODA matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates.In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings.RESULTSIn 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings.This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment.CONCLUSIONSThis case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment.
The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates. In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%). with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings. This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment.
The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. A matched case-control design was performed. Mortality data from 1985-1996 state vital statistics were used to identify 564 cases of sudden death occurring at ages 7 through 19 years across the United States along with a matched group of 564 young people who died as passengers in motor vehicle traffic accidents. The primary exposure measure was the presence of amphetamine, dextroamphetamine, methamphetamine, or methylphenidate according to informant reports or as noted in medical examiner records, toxicology results, or death certificates. In 10 (1.8%) of the sudden unexplained deaths it was determined that the youths were taking stimulants, specifically methylphenidate; in contrast, use of stimulants was found in only two subjects in the motor vehicle accident comparison group (0.4%), with only one involving methylphenidate use. A significant association of stimulant use with sudden unexplained death emerged from the primary analysis, which was based on exact conditional logistic regression (odds ratio=7.4, 95% CI=1.4 to 74.9). A comprehensive series of sensitivity analyses yielded qualitatively similar findings. This case-control study provides support for an association between the use of stimulants and sudden unexplained death among children and adolescents. Although sudden unexplained death is a rare event, this finding should be considered in the context of other data about the risk and benefit of stimulants in medical treatment.
Author Gould, Madelyn S.
Olfson, Mark
Greenhill, Laurence
Cooper, Thomas
Kleinman, Marjorie
Munfakh, Jimmie Lou
Walsh, B. Timothy
Duan, Naihua
Author_xml – sequence: 1
  givenname: Madelyn S.
  surname: Gould
  fullname: Gould, Madelyn S.
– sequence: 2
  givenname: B. Timothy
  surname: Walsh
  fullname: Walsh, B. Timothy
– sequence: 3
  givenname: Jimmie Lou
  surname: Munfakh
  fullname: Munfakh, Jimmie Lou
– sequence: 4
  givenname: Marjorie
  surname: Kleinman
  fullname: Kleinman, Marjorie
– sequence: 5
  givenname: Naihua
  surname: Duan
  fullname: Duan, Naihua
– sequence: 6
  givenname: Mark
  surname: Olfson
  fullname: Olfson, Mark
– sequence: 7
  givenname: Laurence
  surname: Greenhill
  fullname: Greenhill, Laurence
– sequence: 8
  givenname: Thomas
  surname: Cooper
  fullname: Cooper, Thomas
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21922188$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19528194$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9PwyAYxonR6Jx-haUx0VvnC7RQEi_G_4nGw1yiJ0ILzVg6Wgs9-O1lbu7gxRMh_J73fXieY7TvWmcQmmCYYszZpeo6O1XLbkoAxBQEZJBxsodGOKd5ygkp9tEIAEgqcvp-hI69X8YrUE4O0REWOSmwyEaIzwatjUtujQqLRDmdzL1J2jqZBbsaGuVC8mK0rVSwrfOJdclHO4SFP0EHtWq8Od2eYzS_v3u7eUyfXx-ebq6fU5XRPKQVKVjFCIWSZEXGsK6B6YKazOA87i0Z1KzMuRa8VHXOFFdQg-EEC4EZaEHH6GIzt-vbz8H4IFfWV6aJzkw7eMk4IywraATP_oDLduhd9CYJidlQiMmM0WQLDeXKaNn1dqX6L_mbRwTOt4DylWrqXrnK-h0XfRGCiyJyVxuu6lvve1PLyoafjEKvbCMxyHVNcl2TjDXJdU3yt6YoZ3_kOyf_CelG-PO---E_qm9gWqZr
CODEN AJPSAO
CitedBy_id crossref_primary_10_1080_10852352_2019_1603672
crossref_primary_10_1007_s00246_013_0810_5
crossref_primary_10_1007_s12024_019_00143_0
crossref_primary_10_1080_09297049_2019_1682131
crossref_primary_10_1080_13651501_2018_1519078
crossref_primary_10_1002_14651858_CD009885_pub2
crossref_primary_10_1016_j_phrs_2010_04_002
crossref_primary_10_5406_amerjpsyc_124_2_0151
crossref_primary_10_1002_pds_4954
crossref_primary_10_1007_s00228_012_1390_7
crossref_primary_10_1016_j_addbeh_2015_10_007
crossref_primary_10_1007_s12402_012_0072_8
crossref_primary_10_1016_j_jaac_2013_09_001
crossref_primary_10_1176_appi_ajp_2009_09101388
crossref_primary_10_1016_j_jaac_2011_07_018
crossref_primary_10_1176_appi_ajp_2009_09101389
crossref_primary_10_1017_S1461145711000095
crossref_primary_10_4137_CMPed_S7868
crossref_primary_10_1007_s00406_014_0522_8
crossref_primary_10_1097_YIC_0000000000000288
crossref_primary_10_1007_s15202_015_0673_0
crossref_primary_10_1038_s41390_018_0256_9
crossref_primary_10_1016_j_hjc_2022_06_005
crossref_primary_10_1080_14740338_2017_1301928
crossref_primary_10_1007_s12402_012_0087_1
crossref_primary_10_5765_jkacap_2017_28_2_70
crossref_primary_10_1177_0009922810397887
crossref_primary_10_3390_healthcare7020055
crossref_primary_10_1016_j_acap_2016_03_011
crossref_primary_10_1016_j_euroneuro_2010_06_011
crossref_primary_10_1016_j_mehy_2012_04_049
crossref_primary_10_1007_s11126_013_9253_7
crossref_primary_10_1007_s40263_019_00686_4
crossref_primary_10_1093_ehjcvp_pvad028
crossref_primary_10_1097_PCC_0000000000000506
crossref_primary_10_1016_j_chc_2022_02_002
crossref_primary_10_1093_pch_14_9_586
crossref_primary_10_1891_EHPP_2022_0011
crossref_primary_10_1111_jce_12744
crossref_primary_10_1007_s00246_012_0516_0
crossref_primary_10_1186_s40199_015_0092_y
crossref_primary_10_1016_j_drugalcdep_2013_04_024
crossref_primary_10_1515_ijamh_2019_0174
crossref_primary_10_1007_s00112_010_2219_z
crossref_primary_10_1007_s13158_012_0064_z
crossref_primary_10_15844_pedneurbriefs_25_12_1
crossref_primary_10_1016_j_jaac_2011_11_008
crossref_primary_10_1517_14740338_2010_503238
crossref_primary_10_1016_j_yapd_2010_08_004
crossref_primary_10_1097_MOP_0b013e328357a7c3
crossref_primary_10_1111_j_1600_0447_2010_01607_x
crossref_primary_10_1016_j_pnpbp_2012_05_021
crossref_primary_10_1891_1559_4343_14_1_5
crossref_primary_10_1093_pch_14_9_579
crossref_primary_10_1161_CIR_0b013e3181d98555
crossref_primary_10_1007_s40263_012_0019_9
crossref_primary_10_1161_CIRCULATIONAHA_110_017228
crossref_primary_10_1002_pds_4164
crossref_primary_10_1161_CIRCULATIONAHA_109_901256
crossref_primary_10_1002_pds_4041
crossref_primary_10_1007_s12152_018_9389_0
crossref_primary_10_1542_peds_2019_2528
crossref_primary_10_1016_j_cll_2012_06_006
crossref_primary_10_1176_appi_ajp_2009_09050619
crossref_primary_10_1016_j_psychsport_2011_12_007
crossref_primary_10_1016_j_arcped_2013_11_001
crossref_primary_10_1517_14740338_2015_1011620
crossref_primary_10_1056_NEJMoa1110212
crossref_primary_10_1177_21676968221116544
crossref_primary_10_1007_s00103_010_1105_0
crossref_primary_10_1016_j_childyouth_2012_01_011
crossref_primary_10_1136_ebmental_2018_300040
crossref_primary_10_1007_s00391_017_1351_y
crossref_primary_10_1521_capn_2013_18_4_1
crossref_primary_10_1177_0009922810368289
crossref_primary_10_1586_ern_09_128
crossref_primary_10_1016_j_cpr_2012_11_005
crossref_primary_10_1176_appi_ajp_2009_09091292
crossref_primary_10_1089_cap_2015_0264
crossref_primary_10_1515_jpem_2022_0344
crossref_primary_10_1007_s00431_018_3281_0
crossref_primary_10_1016_j_labeco_2016_05_018
crossref_primary_10_1097_CRD_0000000000000234
crossref_primary_10_1177_1087054712455504
crossref_primary_10_1016_j_neurenf_2010_02_004
crossref_primary_10_1176_appi_ajp_2011_11010125
crossref_primary_10_1177_0093854812437015
crossref_primary_10_1002_14651858_CD012069_pub2
crossref_primary_10_1007_s40263_017_0410_7
crossref_primary_10_1111_jcpp_12036
crossref_primary_10_1186_2193_1801_3_286
crossref_primary_10_1016_j_yrtph_2015_04_022
crossref_primary_10_1176_appi_ajp_2011_10111705
crossref_primary_10_1089_cap_2018_0052
crossref_primary_10_2139_ssrn_4883850
crossref_primary_10_2165_11532570_000000000_00000
crossref_primary_10_1111_bcp_12474
crossref_primary_10_1007_s00787_010_0140_6
crossref_primary_10_1097_FAD_0000000000000019
crossref_primary_10_1016_j_jaac_2011_11_013
crossref_primary_10_5402_2012_170935
crossref_primary_10_1002_pds_1992
crossref_primary_10_1038_clpt_2010_82
crossref_primary_10_1017_S1047951111000928
crossref_primary_10_1891_EHPP_D_20_00024
crossref_primary_10_1080_14740338_2017_1389894
crossref_primary_10_1136_bmjpo_2024_002753
crossref_primary_10_1007_s00246_012_0162_6
crossref_primary_10_1016_S0246_1072_12_53147_0
crossref_primary_10_1016_S0828_282X_09_70157_6
crossref_primary_10_3389_fnins_2022_1020961
crossref_primary_10_3109_15563651003720234
crossref_primary_10_1007_s15014_015_0314_2
crossref_primary_10_1055_s_0032_1305091
crossref_primary_10_1080_14681366_2019_1624599
crossref_primary_10_1016_j_addbeh_2015_01_022
crossref_primary_10_1542_peds_2019_2832
crossref_primary_10_1097_MED_0000000000000587
crossref_primary_10_1007_s10840_012_9755_5
crossref_primary_10_1186_1471_2261_12_41
crossref_primary_10_1007_s00787_018_1217_x
crossref_primary_10_1007_s11906_019_0968_1
crossref_primary_10_1016_j_euroneuro_2012_06_011
crossref_primary_10_1016_S0084_3954_09_79647_2
crossref_primary_10_1177_1534650112440741
crossref_primary_10_1542_peds_2011_1574
crossref_primary_10_1089_cap_2015_0239
crossref_primary_10_1586_ern_11_175
crossref_primary_10_1016_S0140_6736_19_33004_1
crossref_primary_10_1111_jpc_16380
crossref_primary_10_1016_j_explore_2010_02_001
crossref_primary_10_1590_S1516_44462009000400022
crossref_primary_10_3345_cep_2021_01466
crossref_primary_10_1016_j_pcl_2010_10_009
crossref_primary_10_1007_s12618_009_0018_z
crossref_primary_10_1016_j_jacc_2020_05_081
crossref_primary_10_1097_MOP_0000000000000388
crossref_primary_10_1007_s40272_012_0001_5
crossref_primary_10_3280_RSF2016_002006
crossref_primary_10_1089_cap_2011_0141
crossref_primary_10_1016_j_childyouth_2010_10_006
crossref_primary_10_1177_0269881111405356
crossref_primary_10_1542_peds_2010_3371
crossref_primary_10_2174_1574886317666220525115232
crossref_primary_10_1016_j_ahj_2012_07_019
crossref_primary_10_1002_pds_2348
crossref_primary_10_1542_peds_2011_2654
ContentType Journal Article
Copyright 2009 INIST-CNRS
Copyright American Psychiatric Association Sep 2009
Copyright_xml – notice: 2009 INIST-CNRS
– notice: Copyright American Psychiatric Association Sep 2009
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
DOI 10.1176/appi.ajp.2009.09040472
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
ProQuest Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1535-7228
EndPage 1001
ExternalDocumentID 1852634001
19528194
21922188
10_1176_appi_ajp_2009_09040472
10.1176/appi.ajp.2009.09040472
Genre Journal Article
Comparative Study
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: R01-MH56250
GroupedDBID ---
--Z
-DZ
-~X
.55
.GJ
08P
0WA
1CY
1HT
1KJ
1QT
23M
2QL
2WC
354
3O-
4.4
41~
53G
5GY
5RE
6J9
6TJ
7K8
85S
8F7
8R4
8R5
AAAHA
AAIKC
AAJMC
AAJWC
AAKAS
AAMNW
AAQQT
AAWTL
AAWTO
AAYJJ
ABIVO
ABPPZ
ABZEH
ACBMB
ACGFO
ACGOD
ACHQT
ACNCT
ADBBV
ADCOW
ADZCM
AENEX
AERZD
AETEA
AFAZI
AFFDN
AFFNX
AFMIJ
AFOSN
AGHSJ
AGNAY
AHJKT
AHMBA
AI.
AIZTS
ALMA_UNASSIGNED_HOLDINGS
ASUFR
BAJDF
BAWUL
BCR
BENPR
BKOMP
BLC
CS3
DIK
E3Z
EBS
EJD
EX3
F20
F5P
F8P
FA8
FJW
G0H
G8K
GOZPB
GRPMH
HF~
HZ~
J5H
L7B
LPU
LXL
LXN
MVM
N4W
N9A
NEJ
NHB
OHT
OK1
OVD
P-O
P2P
PEA
PQQKQ
Q.-
Q2X
RAY
RWL
RXW
RYA
S10
SJN
SKT
TAE
TEORI
TR2
TWZ
UBC
UHB
UKR
ULE
UPT
UQL
VH1
VVN
WH7
WHG
WOQ
WOW
X4V
X6Y
X7M
XJT
XOL
XSW
XZL
YCJ
YFH
YOC
YQI
YQJ
YRY
YSK
YWH
YXB
YYQ
YZZ
ZCA
ZGI
ZHY
ZKB
ZRR
ZXP
ZY1
~A~
~G0
~X8
AAYXX
ABDPE
ADGHP
ADMHG
CITATION
H13
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-a435t-c286c6230b248461df06d83e4e15ddeb60f6b57d97baf56a7a0f0e72199160d93
ISSN 0002-953X
1535-7228
IngestDate Fri Jul 11 09:24:34 EDT 2025
Mon Jun 30 05:41:26 EDT 2025
Mon Jul 21 05:43:32 EDT 2025
Wed Apr 02 07:36:10 EDT 2025
Tue Jul 01 01:51:34 EDT 2025
Thu Apr 24 22:58:28 EDT 2025
Wed Jul 24 08:10:55 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Cardiovascular disease
Cardiocirculatory arrest
CNS stimulant
Psychotropic
Sudden death
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a435t-c286c6230b248461df06d83e4e15ddeb60f6b57d97baf56a7a0f0e72199160d93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
PMID 19528194
PQID 220473015
PQPubID 40661
PageCount 10
ParticipantIDs proquest_miscellaneous_67626483
proquest_journals_220473015
pubmed_primary_19528194
pascalfrancis_primary_21922188
crossref_citationtrail_10_1176_appi_ajp_2009_09040472
crossref_primary_10_1176_appi_ajp_2009_09040472
appi_journals_10_1176_appi_ajp_2009_09040472
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-09-01
PublicationDateYYYYMMDD 2009-09-01
PublicationDate_xml – month: 09
  year: 2009
  text: 2009-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Arlington, VA
PublicationPlace_xml – name: Arlington, VA
– name: United States
– name: Washington
PublicationTitle The American journal of psychiatry
PublicationTitleAlternate Am J Psychiatry
PublicationYear 2009
Publisher American Psychiatric Association
Publisher_xml – name: American Psychiatric Association
References 20123922 - Am J Psychiatry. 2010 Feb;167(2):213-4; author reply 214-5
20123924 - Am J Psychiatry. 2010 Feb;167(2):214; author reply 214-5
19528196 - Am J Psychiatry. 2009 Sep;166(9):955-7
20123923 - Am J Psychiatry. 2010 Feb;167(2):213; author reply 214-5
References_xml – reference: 20123924 - Am J Psychiatry. 2010 Feb;167(2):214; author reply 214-5
– reference: 19528196 - Am J Psychiatry. 2009 Sep;166(9):955-7
– reference: 20123922 - Am J Psychiatry. 2010 Feb;167(2):213-4; author reply 214-5
– reference: 20123923 - Am J Psychiatry. 2010 Feb;167(2):213; author reply 214-5
SSID ssj0000372
Score 2.4053884
Snippet Objective: The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained...
The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in...
SourceID proquest
pubmed
pascalfrancis
crossref
appi
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 992
SubjectTerms Accidents, Traffic - mortality
Accidents, Traffic - statistics & numerical data
Adolescent
Adolescent Behavior - psychology
Adult
Age Distribution
Attention deficit hyperactivity disorder
Biological and medical sciences
Case-Control Studies
Cause of Death
Central Nervous System Stimulants - adverse effects
Central Nervous System Stimulants - therapeutic use
Child
Child & adolescent psychiatry
Children & youth
Coroners and Medical Examiners - statistics & numerical data
Death Certificates
Death, Sudden - epidemiology
Dextroamphetamine - adverse effects
Drug therapy
Fatalities
Female
Humans
Logistic Models
Male
Medical sciences
Methamphetamine - adverse effects
Methylphenidate - adverse effects
Mortality
Neuropharmacology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Risk Factors
Stimulants
United States - epidemiology
Title Sudden Death and Use of Stimulant Medications in Youths
URI http://dx.doi.org/10.1176/appi.ajp.2009.09040472
https://www.ncbi.nlm.nih.gov/pubmed/19528194
https://www.proquest.com/docview/220473015
https://www.proquest.com/docview/67626483
Volume 166
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqISEkhPheGYw88AZhiRM7ySOgTWO042GtKE-R7dhSRptWbfIAfwp_LefY-dIGA16iKpZTx3f5-c6-ux9CrzjnQoiEuREsF25ImXQZ8YUbKuXzDHMSJTpReHpOT-fh2YIsRqOfvailquRvxY9r80r-R6pwD-Sqs2T_QbLtQ-EG_Ab5whUkDNe_kvFFpWEDMIPZBLW52Zm_KPNVtYQ5s-cwbbz4V02Yt-sbpLMus6Tol5EYRkGbCvqWDHuqK0t-L7pN0y_wovXuzPtG9J0YC8W-1W1n-WqVy9eTddVi_FLmhd2AnbLt5Xqby8EmRBdlVfbi_hvUNgwjV_SrQ-CE1BzAsP40oKspdW2SeIPKhozFql_Sw9jEkOddxf6oLnq80TmAl00p0gRAKjTkQMNi2-ef05P5ZJLOjhezYavxjWKCaQAAB571LQwuSO2uf_zUrfJBhBvXSr-PzT6HQRxdPwRY83XDwP65u2E7-BSV4VD5vZNTGzuz--ie9VKcd0blHqCRLB6i21Mbh_EIRUbznFrzHNA8BzTPWSun1Tynp3lOXjhG8x6j-cnx7MOpayk4XAZ2dOkKHFMBFrLHcQiWqp8pj2ZxIEPpE_gfTj1F4XvOkogzRSiLmKc8GWEdUEe9LAmeoL1iXch95AQiwAorTgSVIYtw7CsmfJUoxcHpF3SM3uj5Sa2q79LaPY1oWt-F6dSMqUnaTOcYkWYeU2HL2WtWleWN_Y7afhtT0OXGHocDMbXd4C0xWMjxGB00cutGjzH0hdWTjNHLthWgW5_HsUKuq11KwRChYRyM0VMj7G5ACdEH3OGzPz75AN3pvsXnaK_cVvIFmMglP6x19Rd-87qi
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sudden+Death+and+Use+of+Stimulant+Medications+in+Youths&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Gould%2C+Madelyn+S&rft.au=Walsh%2C+B+Timothy&rft.au=Munfakh%2C+Jimmie+Lou&rft.au=Kleinman%2C+Marjorie&rft.date=2009-09-01&rft.pub=American+Psychiatric+Association&rft.issn=0002-953X&rft.eissn=1535-7228&rft.volume=166&rft.issue=9&rft.spage=992&rft_id=info:doi/10.1176%2Fappi.ajp.2009.09040472&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=1852634001
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-953X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-953X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-953X&client=summon